Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s00198-012-1926-9 | DOI Listing |
BJOG
March 2021
1st Department of Obstetrics and Gynaecology, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Curr Med Res Opin
August 2020
Department of Clinical Biochemistry and Department of Surgery, Royal Free Hospital Campus, University College Medical School, University College London, London, UK.
J Clin Lipidol
July 2020
Department of Medicine, Lipid Clinic and Cardiovascular Risk Reduction Program, Emory University, Atlanta, GA, USA.
J Clin Lipidol
July 2020
National Heart & Lung Institute, Imperial College London, Royal Brompton & Harefield NHS Foundation Trust, London, UK.
Expert Opin Pharmacother
January 2020
Department of Internal Medicine, School of Medicine, University of Ioannina, Ioannina, Greece.
: Hypertriglyceridemia is associated with both the development of cardiovascular disease (CVD) when mild-to-moderate and high risk of pancreatitis when more severe. The residual CVD risk after low-density lipoprotein cholesterol (LDL-C) lowering is, in part, attributed to high triglyceride (TG) levels. Therefore, there appears to be a need for effective TG-lowering agents.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!